Oncology Institute (TOIIW) Free Cash Flow (2020 - 2026)

Oncology Institute (TOIIW) has reported Free Cash Flow for 7 consecutive years, with -$3.3 million the latest figure, recorded in Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$3.3 million, up 38.73% year-over-year; the trailing twelve-month figure through Mar 2026 was -$25.7 million (down 33.06% YoY), and the FY2025 annual result was -$27.8 million, up 8.38% from the prior year.
• Free Cash Flow was -$3.3 million for Q1 2026 at Oncology Institute, down from $2.2 million in the prior quarter.
• Over five years, Free Cash Flow peaked at $2.2 million in Q4 2024 and troughed at -$21.6 million in Q3 2022.
• Average Free Cash Flow over 5 years is -$9.7 million, with a median of -$10.5 million recorded in 2022.
• Year-over-year, Free Cash Flow tumbled 11501.94% in 2022 and surged 147.22% in 2024.
• Over 5 years, Free Cash Flow stood at -$10.5 million in 2022, then jumped by 54.56% to -$4.8 million in 2023, then soared by 147.22% to $2.2 million in 2024, then retreated by 3.21% to $2.2 million in 2025, then slumped by 249.88% to -$3.3 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were -$3.3 million in Q1 2026, $2.2 million in Q4 2025, and -$13.2 million in Q3 2025.